Error: Could not add to watchlist. X

Rydex Series - Biotechnology Fund

+ Watchlist
RYOAX:US
NASDAQ GM
60.35
USD
1.98
3.18%
As of 09:29:30 ET on 02/05/2016.
Fund Type
Open-End Fund
52Wk Range
60.35 - 97.28
1 Yr Return
-21.22%
YTD Return
-24.60%
Open
60.35
Day Range
60.35 - 60.35
Previous Close
62.33
52Wk Range
60.35 - 97.28
1 Yr Return
-22.34%
YTD Return
-24.60%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 02/05/2016)
60.35
Total Assets (m USD) (on 02/05/2016)
392.296
Inception Date
04/01/1998
Last Dividend (on 11/17/2015)
1.276
Dividend Indicated Gross Yield
-
Fund Managers
MICHAEL PAUL BYRUM / RYAN A HARDER
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
-
12b-1 Fee
0.25%
Current Mgmt Fee
0.85%
Expense Ratio
1.83%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 366.40 k 37.08 m 5.98
Amgen Inc 211.40 k 34.32 m 5.54
Celgene Corp 258.61 k 30.97 m 5.00
Biogen Inc 83.18 k 25.48 m 4.11
Regeneron Pharmaceuticals Inc 42.39 k 23.01 m 3.71
Alexion Pharmaceuticals Inc 109.07 k 20.81 m 3.36
Vertex Pharmaceuticals Inc 140.87 k 17.73 m 2.86
Illumina Inc 89.92 k 17.26 m 2.78
Mylan NV 301.31 k 16.29 m 2.63
Endo International PLC 264.40 k 16.19 m 2.61
Profile
Rydex Series - Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests its assets in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products.
ADDRESS
Rydex Funds
9601 Blackwell Road
Suite 500
Rockville, MD 20850
PHONE
1-301-296-5100